Banner promoting anonymous crime reporting with a phone and contact number 1 800 TIPS (8477), featuring the Crime Stoppers logo and a QR code for submitting tips.

← Back

Your message to the BLOGMASTER was sent

416 responses to “Prime Minister David Thompson Has Pancreatic Cancer – Matters Of The Pancreas”


  1. @Doc GP

    One cannot but marvel at how the anatomy is put together. Certainly one of the wonders of all times. Slide #4 is especially foreboding. Is it a reasonable position to have that if one develops a tumor in the pancreas/stomach they should make peace and enjoy the rest of their days as the circumstance allows like Pat suggested?

    BU thinks this would be a more value added decision to make in the context of having a family.

  2. Georgie Porgie Avatar
    Georgie Porgie

    Re Is it a reasonable position to have that if one develops a tumor in the pancreas they should make peace and enjoy the rest of their days as the circumstance allows like Pat suggested?

    YES
    A diagnosis of carcinoma of the pancreas is a curtain raiser – worse than a death sentence!

    The prognosis for a cancer of the stomach is not as bad. A stomach cancer does not have the structures crowding all around it in a confined space as the pancreas does. Also it is not as close to those e maguffy blood vessels!


  3. @GP

    Thanks!

    Your comment on the stomach, how would a regime of dieting impact on someone who has contracted cancer of the stomach?

  4. Georgie Porgie Avatar
    Georgie Porgie

    You must remember that most folk with cancers tend to be anorexic. They tend to eat very little either because of thier illness or the treatment.

    But I guess they can get a suitable regime from a nutritionist.

    I read that in Japan where the disease is caught very early, the prognosis is for a 50% five year survival, whereas for late diagnosis the prognosis is for a 15 % five year survival.

    But dont confuse pancreas with stomach. Remember the pancreas is both an exocrine and an endocrine organ (especially insulin and glucagon). So disease of the pancreas is more severe than that of the stomach all around.

    Hope this helps


  5. @GP

    Understand the point about the severity of a tumour in the pancreas versus the stomach.

    If Person A has stomach cancer please explain how diet followed by surgery can correct/relieve the patient?

    If Person B has pancreatic cancer please explain how good diet followed by possible surgery can correct/relieve the patient?

  6. Georgie Porgie Avatar
    Georgie Porgie

    David I am not a nutritionist or dietician, and am not sure what is the composition of these diets.

    Note that both of the patients you describe will probably not be eating well OK

    Lets say that the stomach patient is fed via a tube and that there pancreas is intact, the pancreas via insulin and glucagon can still contribute to regulating thier metabolism.

    A patient with stomach intact but with severe pancreatic disease is in deep metabolic do doo.

    Does that make sense?

  7. Georgie Porgie Avatar
    Georgie Porgie

    Think of the stomach as a bag with some digestive enzymes and acid where digestion begings, but the pancreas secretes enzymes and participates in digestion in addition to regulating sugar levels in the blood, and regulating metabolism generally.

    So you dont want to mess with your pancreas……..or liver!

    We can by pass the stomach for example as is done in the treatment of obesity……………..bnut you cant really bypass the pancreas.


  8. Roger that GP!

  9. Georgie Porgie Avatar
    Georgie Porgie

    David
    This is an interesting poem on the subject from the Path guy’s website
    A POEM ABOUT THE PANCREAS

    Even if you open up a practice
    On Harley Street
    No patient will come in with complaints
    about his pancreas:
    “I think it’s my pancreas, Doc!”
    — unless he’s a fellow professional
    also educated
    out of his natural mind; few patients
    will be alarmed by the word — how unlike
    “the heart”
    a word that means “the biscuit”
    to the best of us.

    Years from now
    when you trundle in
    thin and yellow, depressed,
    for abdominal films,
    you too will have forgotten
    your pancreas; and the news “It’s cancer
    of the pancreas” will hit
    like an old family secret you knew all along;
    “I’m sorry, but it’s cancer
    of the sweetbread!”
    “Not the sweetbread!” — “Yes,
    and, with proper medical management
    early surgery
    and a very rigid diet
    you can look forward to at least
    another three months”; when the pancreas goes
    it goes.

    Those among us who are diabetic
    whom the pancreas torments
    by degrees
    cannot describe that Familiar; even a poet
    is at a loss for a metaphor;
    nothing short of a surgical exploration
    will unearth
    the thick spongy worm
    buried deep in the viscera
    silent behind its curtain of peritoneum;
    — with a head, a body,
    and a tail,
    using the man’s face.

    –Ron Charach, M.D.
    NEJM 301: 508 (1979)


  10. For those interested in what the Big C does to the pancreas you can have a LOOK compliments of Doc GP.

    If you are squeamish please move on!


  11. Doc, re the Whipple Procedure, it appears that there is much success in some cases, is it correct that these are early stage only?

    For example, USC indicates that they have had much success (checked online).

    Secondly, if you cannot do more traditional surgery, then why not using laser, which ‘should’ be able to literally dissolve or burn away unwanted sections and masses?

    The balance to be dealt with by chemical intervention?

    OR, why not direct intervention, say by chemicals, injected directly to area, to address specific masses?

    Although surgical procedure may be very accurate to an extent, as you point out, due tot he adjacent and interwoven structures, suregery is difficult. But, to a layman such as me this seems like a perfect candidate procedure for using laser?


  12. Thanks GP.


  13. Doc, and third, why not literally (by laser or otherwise) burn away the offending panceas (if not metastisized) and just as for diabetics, give injection of the relevant digestive units required for digestion?


  14. Doc, or (and you all are going to think me nuts), remove the pancreas and then the individual is fed from then on by IV??

    Say, home IV, three times a day?

    Is that far-fetched?


  15. For those who are unfamiliar with the purpose the pancreas serves, have a read–

    A quick trip to Yahoo! Reference revealed that the pancreas is a small, irregularly shaped organ that resides between your stomach and your spine. The pancreas has two primary purposes: to secrete enzymes into your digestive system that help break down carbohydrates and protein, and to produce hormones that help maintain normal blood sugar levels.

    The pancreas is technically part of the endocrine system, though it plays an important role in the digestive system as well. The endocrine system is a collection of glands, including your pituitary, thyroid, and adrenal glands, that secrete hormones to monitor your metabolism and cell growth, among many other things.

    The islets of Langerhans are specialized patches of endocrine tissue that are found throughout the pancreas and are involved in hormone production. Beta cells, the most common type of cells in the islets, produce insulin, which regulates blood glucose. Insufficient insulin results in diabetes mellitus.

    Another disease associated with the pancreas is pancreatic cancer. According to Pancreatica, a medical resource for pancreatic cancer patients and survivors, each year about 29,000 people in the United States are diagnosed with adenocarcinoma of the pancreas.

    Further reading:

    What causes pancreatic cancer?

    While it is virtually impossible to tell what caused a specific person to develop pancreatic cancer, there are some important principles of cancer biology that can help us understand why pancreatic cancer develops, and large population-based studies help us understand the many risk factors for this disease.

    Pancreatic cancer is fundamentally a disease caused by damage to the DNA (mutations). These mutations can be inherited from mom or dad, or they can be acquired as we age. First, let us look at the inherited mutations. Remember that we have two copies of each gene – one copy we inherit from mom, the other copy we inherit from dad. Most individuals with an inherited cancer syndrome inherit one mutant copy (let us say from dad) and one intact (normal) copy (let us say from mom) of a cancer associated gene. As they age, some of these people will damage the good copy of the gene (the copy they got from mom) in a cell in their pancreas. That cell will have two bad copies of the gene, and, as a result, that cell in the pancreas will grow into a cancer. It doesn’t mean that everyone with an inherited predisposition will get cancer, it means that since they only have one copy of the gene, they are more likely to get cancer. I like to think of it using the analogy of the space shuttle, with the shuttle standing in for a person, and computers on the space shuttle standing in for genes. Normally the shuttle goes into space with a computer and a back-up for that computer. Only if both computers break is there a problem. For people with a genetic predisposition to pancreatic cancer, it is like going up into space with one good computer and one bad computer. If something goes wrong with the one good computer, they are in trouble.

    The second way we can damage our DNA is with our behavior. The carcinogens in cigarette smoke can damage our DNA. If the carcinogens damage a key cancer-associated gene in a cell in the pancreas, then that cell may grow into a cancer. Simply put, don’t smoke! The third way our DNA gets damaged is by chance. This is probably the least satisfying explanation, but it is true. Every cell in our body (and there are trillions of them!) contains a 23 chromosomes and these 23 chromosomes contain 3 billion base-pairs of DNA. Every time a cell divides it has to copy all of that DNA (so that it can make a daughter cell with a full complement of DNA). The DNA copying machinery in cells is pretty darn good, but it is not perfect. Occasionally mistakes are made. On one hand, this is good from a population or species perspective, because these mistakes allow for evolution to occur (if we copied our DNA perfectly we would not evolve!). If one of these chance errors in copying (DNA mutations) damage a key cancer-associated gene in a cell in the pancreas, then that cell may grow into a cancer.

    To summarize, pancreatic cancer is caused by DNA mutations, and there are three ways that we can damage our DNA. We can be born with a DNA mutation inherited from mom or dad, we can do something, like smoke, that damages our DNA, or our DNA can be damaged by chance.

    The second way to answer the question about what causes pancreatic cancer is to ask what are the risk factors for pancreatic cancer? Some of the risk factors include:

    Cigarette smoking: Smoking doubles the risk of pancreatic cancer. Smoking is also associated with early age at diagnosis, and, very importantly, the risk of pancreatic cancer drops close to normal in people who quit smoking. Simply put, cigarette smoking is the leading preventable cause of pancreatic cancer. In fact, some scientists have estimated that one in four, or one in five cases of pancreatic cancer are caused by smoking cigarettes.
    Age: The risk of developing pancreatic cancer increases with age. Over 80% of the cases develop between the ages of 60 and 80.
    Race: Studies in the United States have shown that pancreatic cancer is more common in the African American population than it is in the white population. Some of this increased risk may be due to socioeconomic factors and to cigarette smoking.
    Gender: Cancer of the pancreas is more common in men than in women. Men are more likely to smoke than women.
    Religious background: Pancreatic cancer is proportionally more common in Ashkenazi Jews than the rest of the population. This may be because of a particular inherited mutation in the breast cancer gene (BRCA2) which runs in some Ashkenazi Jewish families.
    Chronic pancreatitis: Long-term inflammation of the pancreas (pancreatitis) has been linked to cancer of the pancreas.
    Diabetes: Diabetes is both a symptom of pancreatic cancer, and long-standing adult-onset diabetes also increases the risk of pancreatic cancer.
    Obesity: Obesity significantly increases the risk of pancreatic cancer.
    Diet: Diets high in meats, cholesterol fried foods and nitrosamines may increase risk, while diets high in fruits and vegetables reduce risk. Folate may be protective.
    Genetics: As mentioned earlier, a number of inherited cancer syndromes increase the risk of pancreatic cancer. These include inherited mutations in the BRCA2, FAMMM, PalB2 or Peutz-Jeghers genes. To learn more about familial pancreatic cancer visit the web site of the National Familial Pancreas Tumor Registry.


  16. A friend of mine was diagnosed with pancreatic cancer in May 2 years ago. The first symptom was an intensely itchy skin. Thought maybe that diabetes was developing. Went to one of the very best hospitals in the U.S. They were unable to help, although they were able to relieve the pain. Was in the grave by August. The spouse was an extremely heavy smoker and had died of a smoking induced disease a year earlier. Cigarettes are far more deadly than many of us want to admit. I have no doubt that they are associated not only with lung cancer but with pancreactic cancer as well.

    If doctors know how to cure pancreactic cancer then they would. But in truth even with access to the very best treatment the rgnosis for pancreatic cancer is still very grim, or as the GP says the diagnosis means that the patient is in deep doo-doo.

  17. Georgie Porgie Avatar
    Georgie Porgie

    David is fast becoming a good medical student.

    J
    You will notice that pruritus (or intense itchy skin) is noted in the symptoms in the ppt due to the hyperbilirubinemia Pancreatic diseases are the usual causes of post hepatic jaundice. I,e jaundice due to causes obstructing the release of bile from the gall bladder.
    Re “The spouse was an extremely heavy smoker and had died of a smoking induced disease a year earlier.” His smoking might have contributed to her pancreatic cancer. Seecauses in ppt. The prognosis for pancreatic cancer is very grim because of the relations of the pancreas (i.e the pancreas is surrounded by very important structures such as liver spleen and the three major blood vessels.

  18. Georgie Porgie Avatar
    Georgie Porgie

    Crusoe
    The Whipple Procedure, is apparently some what successfull in early stages
    Note that the pancreas is retroperitoneal, so it is not palpable at routine examinations.
    You really have to appreciate the relations of the pancreas to understand the difficulty of its treatment and the fact that it spreads easily to important organs as indicated in the ppts.

    Your suggestion to use laser “to literally dissolve or burn away unwanted sections and masses” is still surgery, and has to circumvent the major problems of the difficulty posed by the relations of the pancreas .

    Also consider the anomalous structure of the blood vessels presented in the ppt on the relations of the pancreas. Just imagine your horror when you think you are cutting pancreatic tumor tissue you are cutting into tributaries of blood vessels or of blood vessels in an anomalous location.

    Re The balance to be dealt with by chemical intervention? How would you do this Sir? Inject into the pancreatic ducts or blood vessels or into tumor tissue?

    I think that you have understood the difficulty of surgery due to “the he adjacent and interwoven structures, he adjacent and interwoven structures.” But I am not sure that you realize that laser surgery is still just surgery except you don’t use a knife. ,
    Re why not literally (by laser or otherwise) burn away the offending pancreas . THIS IS OF COURSE THE PURPOSE OF SURGERY. The trouble is that by the time the diagnosis is made the cancer has spread ( metastasized). Did you see the picture with that liver? There is almost as much cancer cells in the liver combined as in the pancreas itself.

    Certainly diabetes and other metabolic issues can be treated to some extent intravenously
    No I don’t think you are nuts. I can see that with the limitations of a layman you are THINKING and seeking solutions to a problem. Of course the aim is to remove the pancreas and then treat the patient by IV. But you are fighting a very uphill battle. Best treatment here is PRAYER. A MIRACLE IS NEEDED . DIVINE INTERVENTION ALONE WIL HELP.

    However, I have read that in Japan where the disease is caught early they have a 50% five year survival.


  19. GP, thanks for your reply.

    I understand that the laser is still surgery, but was thinking that as laser is (I thought) accurate to the finest detail, that with adequate imaging and use of laser combined, one could circumvent some of the issues with conventional surgery.

    Point taken on the diagnosis and timing of such, as related to treatment.

  20. Georgie Porgie Avatar
    Georgie Porgie

    I see where you are coming from Crusoe, but we have to consider so many other metabolic and pathological vagaries of cancer, including theside effects of the drugs. But the late diagnosis and the location of the pancreas are major obstacles.


  21. GP, Thanks and understood.


  22. Dear GP:

    If as you ae saying the risk factors for pancreatic cancer are:
    – Cigarette smoking
    – High intake animal fat and meat
    – Chronic pancreatitis from alcohol most commonly

    In other words the risk factors are largely risk factors of affluence or as we call it in Barbados “living large” that is access to plenty of cigarettes, alcohol, meat and other animal fats is this cancer then largely a cancer of modern affluence, and can the risk factors be reduced by returning to a more simple life. No cigarettes, only a little bit of meat, and little or no alcohol?

  23. Georgie Porgie Avatar
    Georgie Porgie

    J
    I read that the incidence of pancreatic cancer has incresed dramatically in the last 50 years, so there is a lot of merit in your hypothesis.


  24. @Doc GP

    You have indicated because of the late diagnosis of pancreatic cancer surgery is mostly useless. Thought BU should post the following for what it is worth to show all is not loss.

    Single-centre experience of laparoscopic pancreatic surgery.

    MedLine Citation:

    PMID:  20474000     Owner:  NLM     Status:  MEDLINE    

    Abstract/OtherAbstract:

    BACKGROUND: Laparoscopic resection is regarded as safe and feasible in selected patients with benign pancreatic tumours. Few data exist on laparoscopic surgery for malignant lesions and larger neoplasms in unselected patients. METHODS: The study included all patients admitted to Oslo University Hospital, Rikshospitalet, from March 1997 to March 2009 for surgery of lesions in the body and tail of the pancreas, and selected patients with lesions in the pancreatic head, who underwent surgery by a laparoscopic approach with curative intent. RESULTS: A total of 166 patients had 170 operations, including 138 pancreatic resections, 18 explorations, nine resections of peripancreatic tissue and five other therapeutic procedures. Four patients had repeat procedures. There were 53 endocrine tumours (31.0 per cent), 28 pancreatic carcinomas (16.4 per cent), five cases of metastases (2.9 per cent), 48 cystic tumours (28.1 per cent) and 37 other lesions (21.6 per cent). The total morbidity rate was 16.5 per cent. Fistula was the most common complication (10.0 per cent). Three patients needed reoperation for complications. There were three hospital deaths (1.8 per cent). Median hospital stay following surgery was 4 days. CONCLUSION: Laparoscopic resection of lesions in the body and tail of the pancreas in an unselected patient series was safe and feasible, and should be the method of choice for this patient group in specialized centres.

    Authors:

    B I R?sok; I P Marangos; A M Kazaryan; A R Rosseland; T Buanes; O Mathisen; B Edwin Publication Detail: Type:  Journal Article; Research Support, Non-U.S. Gov’t    

    Journal Detail: Title:  The British journal of surgery     Volume:  97     ISSN:  1365-2168     ISO Abbreviation:  Br J Surg     Publication Date:  2010 Jun

    Date Detail: Created Date:  2010-05-17     Completed Date:  2010-06-10     Revised Date:  -     Medline Journal Info: Nlm Unique ID:  0372553     Medline TA:  Br J Surg    Country:  England    

    Other Details: Languages:  eng     Pagination:  902-9     Citation Subset:  AIM; IM   

    Affiliation: Division of Surgery, Section for Gastrointestinal Surgery, Oslo University Hospital (OUH), Rikshospitalet, 0027 Oslo, Norway.

    Export Citation: APA/MLA Format Download EndNote Download BibTex

  25. Georgie Porgie Avatar
    Georgie Porgie

    David did you see the phrase benign pancreatic tumors.

    I suspect that one might use laparoscopy to see whats going on.

    Also I am sure you have not witnessed the opening and quick closing of a patients abdomen when a pancreatic tumor is discovered.

    Have you figured out why the proceddure is done this way?

    Dont think they will really cure malignant pancreatic tumors this way.


  26. benign=NOT cancerous
    malignant=cancerous

    Also David please not form the article which you psoted above “Few data exist on laparoscopic surgery for malignant lesions ”

    The data that you are looking for just does not exist. Guess why?


  27. On a quick check for ‘direct injection’ possibilites, I came acroos one current vaccine trial”

    Direct-Injection Vaccine Combo Tested for Pancreas Cancer
    Released: 2/10/2010 8:00 AM EST
    Source: Cancer Institute of New Jersey

    Newswise — More than 42,500 people in the United States were diagnosed with pancreatic cancer last year and nearly 35,200 died from the disease, according to The American Cancer Society. The lifetime risk of developing pancreatic cancer is about one in 76 for both men and women and there is a five-year survival rate of only five percent, despite advancements in surgery, chemotherapy and radiation treatment. That is why researchers at The Cancer Institute of New Jersey (CINJ) are investigating the development of a series of vaccine injections to see if they will produce an immune response against pancreatic cancer. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

    It has been known for a number of years based on studies by scientists at CINJ and elsewhere, that the presence of a tumor in the body can actively inhibit the immune system from recognizing and destroying these same tumors. Studies on mouse models at CINJ have shown this blockade of immunity also prevents traditional cancer vaccines from producing a good response.

    As part of these studies at CINJ, investigators have shown that injecting a vaccine and other immunity-producing drugs into the tumor itself — rather than the traditional site of the skin — can result in a reversal of the immune blockade and the development of specific immunity to the tumor. This body-wide tumor-specific immunity has the potential of inhibiting the growth of the original tumor as well as eliminating small deposits of tumor that can form metastases.

    These findings have led to the development of a vaccine strategy targeting patients with pancreatic cancer, where the vaccine would be injected directly into the tumor. It is believed that this trial would be the first such study to evaluate direct injection into a pancreas tumor to enhance the body’s immune response to help fight the cancer.

    Elizabeth Poplin, MD, medical oncologist at CINJ and professor of medicine at UMDNJ-Robert Wood Johnson Medical School, is the lead researcher on this clinical trial sponsored by the National Cancer Institute, which will look at the investigational vaccine known as PANVAC. PANVAC has special genes added to it that might stimulate a person’s immune system to recognize and develop an immune response to the disease.

    “There has not been a significant breakthrough in the treatment of pancreatic cancer since an upgrade in chemotherapy in the mid 1990s,” said Dr. Poplin. “When you talk about a disease that on average carries only a five-percent survival rate, the possibility of identifying better treatment and management options, especially by potentially utilizing the body’s own defenses, has become a challenge that my colleagues and I are committed to tackling.”

    Two types of PANVAC will be utilized in the two-year study, which will test approximately a dozen patients whose pancreatic cancer cannot be removed through surgery. PANVAC-V, which uses the same virus as the smallpox vaccine, is a live but weakened vaccinia vaccine (meaning the virus can still multiply) that will be given in the arm. PANVAC-F (a live Fowlpox virus that cannot multiply) would be injected into the arm and into the tumor itself. Direct tumor injection would take place through a procedure known as endoscopic ultrasound, in which a scope is inserted through the mouth and into the stomach. From inside the stomach, the pancreas can be seen clearly, allowing injection of the vaccine into the tumor.

    Tamir Ben-Menachem, MD, gastroenterologist at CINJ; director of endoscopy and associate professor of medicine at UMDNJ-Robert Wood Johnson Medical School, is an investigator on the research team who will perform the endoscopies. “Traditionally, vaccination treatment is always administered away from the affected site. In recent years, technology has advanced far enough to allow us to explore the option of injecting the tumor directly,” said Dr. Ben-Menachem. “It is my hope and that of the investigative team here at CINJ that we will be able to compile enough data to bring us to the next level of research. It is only through such study that we will be able to learn more about the process and improve the treatment of pancreatic cancer.”

    Patients with pancreatic cancer that is either localized to the pancreas but cannot be removed by surgery, or has minimally spread beyond the pancreas, are eligible to take part in the study, although other criteria must be met. For more information on how to take part, individuals should call CINJ’s Office of Human Research Services at 732-235-8675.

    Clinical trials, often called cancer research studies, test new treatments and new ways of using existing treatments for cancer. At CINJ, researchers use these studies to answer questions about how a treatment affects the human body and to make sure it is safe and effective. There are several types of clinical trials that are currently underway at CINJ, including those that diagnose, treat, prevent, and manage symptoms of cancer. Many treatments used today, whether it is drugs or vaccines; ways to do surgery or give radiation therapy; or combinations of treatments, are the results of past clinical trials.


  28. And on direct injection of ‘gold nanoparticles’:

    ScienceDaily (Mar. 22, 2010) — Pancreatic cancer — known as the most fatal cancer with no known effective treatment — requires a radical new therapy. A promising approach may come in the form of tiny gold nanoparticles — loaded with a therapeutic agent to kill cancer — in a novel procedure called “nanoembolization,” said researchers at the Society of Interventional Radiology’s 35th Annual Scientific Meeting in Tampa, Fla.

    ——————————————————————————–

    “As current treatments for pancreatic cancer offer minimal benefit, entirely new approaches are needed. We’ve developed a radically different approach that might be able to overcome some of the obstacles that have hampered previous therapies for pancreatic cancer,” said Reed A. Omary, M.D., M.S., an interventional radiologist and professor of radiology and biomedical engineering and vice chair of research in the radiology department at Northwestern University in Chicago, Ill. Traditional attempts to treat this particularly horrible cancer include some combination of chemotherapy, radiation therapy, and/or surgery. However, none of these methods results in effective treatment.

    Instead, Northwestern researchers constructed extremely tiny particles made out of gold — termed nanoparticles — with cancer-killing agents attached to them. These nanoparticles, which measure only 13 nanometers in diameter, are so small that 8,000 of them could be strung together and still occupy less than the width of a single human hair. In animal studies, the research team used an interventional radiology technique to inject the cancer-killing nanoparticles directly into the tumor. The investigators call this novel delivery technique “nanoembolization.” Omary said, “Using nanoembolization, we dramatically increased the concentration of the nanoparticles in the tumor by 55 times over traditional methods that use a vein (such as at the elbow). That’s a massive improvement — and a promising discovery for this dreadful disease.”

    The pancreas is the organ located behind the stomach. It produces juices that help break down food and hormones that help control blood sugar levels. Pancreatic ductal adenocarcinoma is the most common type of pancreatic cancer and carries the worst prognosis of any cancer, even when diagnosed early. This aggressive cancer typically has a six-month survival rate at diagnosis. In 2009, it was estimated that more than 42,000 individuals, typically over the age of 60, were diagnosed with pancreatic cancer, making it the fourth-leading cause of cancer death in the United States. Because it is often found late and it spreads quickly, pancreatic cancer can be hard to treat.

    “As current treatments offer minimal benefit, entirely new approaches are needed,” said Omary, in explaining the pre-clinical study. A major reason that current pancreatic cancer treatments do not work is that scar tissue develops around the cancer. This scar tissue blocks cancer-killing drugs from entering the tumor in the first place, said Omary.

    “We used a catheter to deliver cancer-killing nanoparticles directly to the tumor. The catheter is placed into an artery near the groin and navigated through blood vessels to the site of the tumor, all without surgery. Once in the blood vessel that supplies the tumor, the catheter can deliver nanoparticles directly into the tumor. This method may offer a better way to overcome the scar tissue that blocks drugs from attacking the tumor,” he added. With this type of catheter delivery, more drug “can go directly where we want it: to the tumor itself,” said Omary. “This is not the case with injections through a vein, where the cancer-killing drug may not end up where it needs to be,” he explained.

    The direct catheter injections also have the potential to reduce some of the side effects such as vomiting and hair loss that may be seen with typical chemotherapy. “Researchers have been using the same tool box for a long time without any benefit; it’s time for us to apply some high-tech tools to treat pancreatic cancer,” said Omary, the senior author of “Image-guided Nanoembolization as a Novel Local Therapy for Pancreatic Cancer: Feasibility in an Animal Model.”

    “For decades, interventional radiology has offered innovative ways to treat cancer patients instead of traditional surgery, chemotherapy or radiation; after all, we invented the field of minimally invasive medicine. Interventional radiologists recognize that the greatest advances in medicine occur at the interface with other medical disciplines,” said Omary. “Nanoembolization is a terrific example of bringing together a diverse range of experts — in interventional radiology, chemistry and oncology — to develop a radically different method to treat the cancer with the most dismal survival rate,” he added.

    Omary praised the efforts of all the Northwestern investigators including nanomedicine experts Chad A. Mirkin, Ph.D., director of the university’s International Institute for Nanotechnology and a member of President Obama’s Council of Advisors for Science and Technology, and C. Shad Thaxton, M.D., Ph.D., assistant professor of urology. Omary emphasizes that before this proposed new treatment is ready for patients, more studies will be needed to show safety and effectiveness.


  29. Thirdly, injection of a bacteria directly to the tumor, also was considered in 2007.

    Gut 2008;57:483-491 doi:10.1136/gut.2007.125419
    Pancreatic cancer
    Pancreatic cancer regression by intratumoural injection of live Streptococcus pyogenes in a syngeneic mouse model
    C Maletzki1, M Linnebacher2, B Kreikemeyer3, J Emmrich1
    + Author Affiliations

    1Division of Gastroenterology, Department of Internal Medicine, University of Rostock, Rostock, Germany
    2Department of General, Thoracic, Vascular and Transplantation Surgery, University of Rostock, Rostock, Germany
    3Department of Medical Microbiology and Hospital Hygiene, Institute of Medical Microbiology, Virology and Hygiene, University of Rostock, Rostock, Germany
    C Maletzki, Division of Gastroenterology, Department of Internal Medicine, University of Rostock, Ernst-Heydemann-Str. 6, D-18055 Rostock, Germany; Claudia.Maletzki@uni-rostock.de
    Revised 28 September 2007
    Accepted 6 November 2007
    Published Online First 19 November 2007
    Abstract
    Background: This study addressed the potential of bacteriolytic therapy using Streptococcus pyogenes in a syngeneic pancreatic carcinoma mouse model.

    Methods: Panc02 tumours were either infected with S pyogenes or were treated with the equivalent volume of vehicle. In addition to assessment of tumour histology and immunohistochemistry, isolated splenocytes were analysed by flow cytometry. Interferon (IFN) γ secretion as a reaction of splenocytes against tumour cells was shown through the ELISpot technique. A cytotoxic effect of lymphocytes against tumour targets was detected by lactate dehydrogenase (LDH) release. Cytokine levels in serum were measured.

    Results: A single application of live bacteria into established Panc02 tumours resulted in complete tumour regression. This antitumoural effect was accompanied by massive leucocyte infiltration into the tumours as well as a significant and sustained elevation of systemic levels of the proinflammatory cytokines IFNγ, tumour necrosis factor α and interleukin 6. Lymphocytes obtained from treated mice specifically recognised syngeneic tumour cells in IFNγ-ELISpot, and most importantly in cellular cytotoxicity assays, indicating a tumour-specific immune response.

    Conclusions: We provide data that both the direct lytic activity of S pyogenes towards tumour cells and the infection-driven infiltration of tumours by cells of the innate immune system lead to damage of tumour cells followed by a dissemination of tumour components. This last outcome allows for the activation of tumour-specific effector cells, most probably in draining lymph nodes, promoted by the proinflammatory context. Taken together, these data indicate that the application of live S pyogenes may be a promising new treatment strategy for advanced pancreatic cancer patients that warrants further investigation.


  30. Thanks Crusoe, some eye opening information provided which gives hope to holders of the disease.


  31. No problem, just a little internet search, no doubt GP is aware of these studies.

    @GP, taking your explanation on the surgical (laser or otherwise) difficulty, it appears that the only way then, if removal is impractical, that elimination at site is necessary.

    Also, chemical or other attack directly at site should have the most potent impact, also bearing in mind your point on the effect of chemcials etc on the body as a whole, should have the least side-effects.

    That must be why these studies are focusing on direct means, such as the nano delivery method.

    So, maybe in a few years when one or all are improved and perfected, all will not be lost, even if only as a percentage success rate?


  32. from above ‘Omary emphasizes that before this proposed new treatment is ready for patients, more studies will be needed to show safety and ‘

    If the illness is so terrible, then why not get release and agreement forms and go for it???

    May sound crass, but its a last resort, no?


  33. This certainly seems to be a grim disease, and must be devastating to bear given the negative prognosis. Appreicate the research and education you guys provided us. would it be possible for the Pm to get access to the new nano technology even if it is in clinical trials? Perhaps this might the operation he is speaking of?

    GP I take your point about adding prayer to the mix. We can pray not only for the P.M. and his family, but let us include the doctors. Certainly for the researchers and clinical trials, because cancer is a dread death that indeed must be halted in its tracks. Much depends too on the emotional strength of the patient and faith of the patient. The PM is definitely reaching out for that. God can and will strengthen him.

  34. Georgie Porgie Avatar
    Georgie Porgie

    Crusoe you have brought some good information to the table, and should be commended highly for doing so.

    This is the sort of educational discussion that one hopes to see on BU on the basis of the fact that we are supposed to be a very literate people.

    A few points worthy of note though.
    Re Patients with pancreatic cancer that is either localized to the pancreas but cannot be removed by surgery, or has minimally spread beyond the pancreas, are eligible to take part in the study, although other criteria must be met.

    Again you come up with the obstacle of early diagnosis.
    How often will a patient that is recently diagnosed (usually late) have a localized tumor that has minimally spread beyond the pancreas?
    Do you suppose that a cancer that cannot be removed by surgery is one that has minimally spread beyond the pancreas?

    There is some lose use of terms in the articles also
    Re Clinical trials, often called cancer research studies, test new treatments and new ways of using existing treatments for cancer.

    Note that this is not the proper definition of a clinical trial. The statement above suggests that cancer research studies are clinical trials, but strictly a clinical trial tests a drug or procedure for efficacy and is required before the drug can be marketed.

    Clinical trials do not diagnose, treat, prevent, and manage symptoms of cancer. A trial is a trial! It is an attempt to ascertain if a drug or procedure can/will work. To prove the mechanism of action etc

    When all is said and done the punch line is that pancreatic cancer is an aggressive cancer that is often found late and that spreads quickly Because it can be hard to treat it typically has a six-month survival rate at diagnosis.

    Since the Japanese diagnose the disease earlier and have a 50% five survival rate, it would be interesting to ascertain information from their research.

    Perhaps one day we can get into the complex theories of how a cancer develops

    Time permitting I will post a ppt on metastasis etc from my Pathology ppt that I taught in the Cooks in 06.


  35. How many of us are willing to reduce our alcohol comsumption to no more than 2 per day for a man and no more than 1 per day for a woman, and none at all for women of child bearing age?

    How many of us are willing to reduce our meat intake half a pork chop, or half a steak, of a single skinless chicken breast, or only an occasional 4 oz serving of pudding and souse?

    How many of us are willing to give up smoking and to forbid smoking in our homes. J has forbidden smoking in this home for decades. NOBODY has ever smoked in my home. Nobody can smoke in my home, not even a Prime Minister.

    We don’t want to disipline ourselves, but when the inevitable happens, we want to call God down from his throne to work miracles.

    J was fortunate to have spent way, way too much time in church and Sunday school, and to have had a wise Anglican priest (no not a white man from up in England, but a black man from right here in the Eastern Caribbean) who long before the Prime Minister was born warned about the dangers of “cutting our throats with our teeth” ie. he warned about the dangers of too much rich food, too many drinks, and too many cigarettes, or to use the term of the PM’s principal political adviser, the goodly priest warned of the dangers of “living large” We really should take more advice from our parents, teachers, and priests. They are almost always right especially when they are saying things that we don’t want to hear.

    A word to the wise is sufficient.

    Actions have consequences.


  36. @J,
    Very well said. I am guilty until now.

    I have a Cholesterol problem that may require medication. I am responsible for ignoring the warning signs. Eat too much fast junk food.

    Now I am trying to eat “sensibly”. Grilled Salmon, Mackerel and skinless chicken. Nuff rabbit food lol. Lettuce,broccoli,cucumber,okra, etc. steelcut oats.

    As much as possible food with no added salt or sugar and exercise.
    I could have been doing this years ago instead of setting myself up for a heart attack.

    Hope some of my big guts friends paying attention to Dr.GP’s presentation about cholesterol.


  37. Given the life expectancy of the holder of pancreatic cancer there is the opportunity to help science progress by participating in treatments which Crusoe has identified in his research. The downside is side affects which maybe debilitating and therefore compromise the quality time left with friends and family*.

    A judgement call is ever there was one.


  38. How very ironic. Wunna Bajans all want to go to heaven BUT none ah wunna want to die! (And be planted!) 🙂

  39. Georgie Porgie Avatar
    Georgie Porgie

    David
    Please kindly permit me to once again stress that the major problem that contributes to the relatively short life expectancy of persons with pancreatic cancer are 1 the peculiar relations of the pancreas and 2 its retroperitoneal location in the confined space of the foramen of Winslow, and the fact that these factors are major factors leading to late diagnosis of this disease

    The side effects of drugs used to treat pancreatic cancer are really no more debilitating than those seen in the treatment of other cancers.

    Because the life expectancy of the patient is so short the opportunity to help science progress by participating in treatments which Crusoe has identified in his research is limited.

    It would seem that better treatment of this disease lies in earlier diagnosis It might behove us to seek to ascertain why/how the Japanese make the diagnosis of this disease earlier thereby leading to a higher 5 year mortality survival

    I am not saying that we should abandon attempts to employ the techniques in trials as researched by Crusoe.


  40. @GP, fair comment and your point on Japan must be the first look-see.

    @de hood. Naughty!!!


  41. @GP. I tried looking up the Japan survival rate. This is just one article, from the Japanese Journal of Oncology. Dont have time to look for more right now.

    Sorry to say, the survivial rates quoted here are not promising, certainly none looking like 50%. Probably because it is looking at a specific group of severely ill, it seems.

    Note that this article is comparing the costs of specific chemical agents i.e. gemcitabine vs others, but some of the tables etc show survivial rates, as I said, this is probably the most severe cases anyhow. This from 2005, so some advances must have occurred also.

    http://jjco.oxfordjournals.org/cgi/content/full/35/9/526#TBL3


  42. @ Crusoe

    & Cheers to you, old chap. 🙂


  43. They say a picture is worth a 1000 words.
    http://www.panoramio.com/photo/37552386


  44. Ooops.!!!!Wrong place.


  45. A relevant presentation to the matter under discussion.

    Compliments Doc GP

  46. Straight talk Avatar

    Could cancer be a fungus, as this oncologist believes?

  47. Straight talk Avatar

    Sorry forgot the link.


  48. Straight Talk, re. your comment at 7:05 pm above.

    I would find it very hard to believe that the cancers illustrated in the video above are primarily caused by a fungus. Fungi are normally quite easy to identify and it would be very strange that, given the billions of dollars spent on cancer research over the years, it is only now that an oncologist is making that claim. Of course there may be a possibility that a fungus might be involved as a secondary parasite involved in the development of the tumours but even then such an association should have been clarified decades ago.

    Re. the claims of bicarbonate of soda effecting some remission of the tumours; It would be interesting to find out how many oncologists have noticed this relationship but more importantly, how they explain why a common dietary salt, with no claims to fungicidal or fungistatic action, controls the putative fungus “causing” the cancer.

    I’d take the claims with a grain of salt for now until more oncologists corroborate the observations with more details and real scientific evidence.

  49. Straight talk Avatar

    Checkit-Out:

    Seems very strange to me too, especially as he has now been struck off.

    But there is that relationship between Human Papilloma Virus and cervical cancer suggesting that some cancers, if not all, are reactions to pathogens.

    As to simple solutions being the answer, the University of Alberta seems be on to something with dichloroacetate (DCA).
    But as it can be bought off the shelf Big Pharma was shy of funding research, but still trials are showing remarkable results.


  50. It was confirmed today by Prime Minister Thompson’s physician that he is suffering from pancreatic cancer. The complication last weekend had to do with a blood clot which developed arising from the procedure he underwent to deal with the tumor in the pancreas.

The blogmaster invites you to join the discussion.

Trending